Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transfusion purpura.

Corina E Gonzalez1, Yolande M Pengetze

  • 1Division of Pediatric Hematology/Oncology, Georgetown University Hospital, 3800 Reservoir Rd, NW, Washington, DC 20007, USA.

Current Hematology Reports
|February 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolution of PML after Treatment with Virus-Specific T Cells and HCT.

The New England journal of medicine·2026
Same author

Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literature.

The Journal of infectious diseases·2026
Same author

Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.

The Journal of allergy and clinical immunology·2026
Same author

Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency.

Journal of human immunity·2026
Same author

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.

Transplantation·2025
Same author

Restoration of the human skin microbiome following immune recovery after hematopoietic stem cell transplantation.

Cell host & microbe·2025
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

Post-transfusion purpura (PTP) is a rare bleeding disorder caused by platelet-specific antibodies. Diagnosis involves detecting these antibodies, with treatments including IVIG and plasmapheresis.

Area of Science:

  • Hematology
  • Immunology
  • Transfusion Medicine

Background:

  • Post-transfusion purpura (PTP) is a rare but serious bleeding disorder.
  • It is primarily caused by alloantibodies targeting human platelet antigens (HPAs), most commonly anti-HPA-1a.
  • Multiparous women are the most affected demographic, often sensitized during pregnancy.

Purpose of the Study:

  • To summarize the understanding of post-transfusion purpura (PTP).
  • To highlight the diagnostic criteria and common causes of PTP.
  • To outline current therapeutic strategies for managing PTP.

Main Methods:

  • Review of existing literature on post-transfusion purpura.
  • Analysis of diagnostic methods for identifying platelet alloantibodies.

Related Experiment Videos

  • Summary of treatment protocols for PTP management.
  • Main Results:

    • PTP is characterized by severe thrombocytopenia, typically resolving spontaneously.
    • Severe or fatal bleeding can occur during the disease course.
    • Diagnosis relies on detecting patient serum antibodies against platelet-specific antigens.

    Conclusions:

    • PTP necessitates prompt diagnosis through antibody detection.
    • Effective treatments include intravenous immunoglobulin, corticosteroids, and plasmapheresis.
    • Understanding PTP pathophysiology is crucial for managing this rare bleeding disorder.